SuspendIt Anhydrous oral suspending vehicle offers improved taste, broader application and prolonged default beyond use dates (BUDs).It is Ideal for active pharmaceutical ingredients (APIs) that are unstable in water or have incompatibilities in some aqueous vehicles,

Its unique self-emulsifying system mixes nicely in aqueous liquids, while its thixotropic effect offers rapid redispersion of APIs with minimal sedimentation. And with water activity less than 0.6 (Aw<0.6), SuspendIt Anhydrous is classified as an anhydrous oral vehicle that, depending on the API used, allows pharmacy compounders to assign longer default BUDs.

Unlike traditional fixed oil suspensions and other oral anhydrous suspensions, SuspendIt Anhydrous mixes easily with water or juice to improve patient compliance. Mixing a single dose of the compounded medication with juice or other flavored liquids at time of administration helps disguise the medication’s taste, which may improve medication compliance in children, hospice patients and pets.

SuspendIt Anhydrous is compatible with polyurethane nasogastric (feeding) tubes for use in hospice, pediatric care and other healthcare settings.

Unique Characteristics of SuspendIt Anhydrous

SuspendIt Anhydrous is unlike any other oral suspension vehicle:

• Self-emulsifying properties may improve the solubility, dispersibility and possibly enhance bioavailability of drugs with poor water-solubility.
• Thixotropic effect potentially allows rapid redispersion of APIs upon agitation with potentially minimal sedimentation.
• Extended BUDs for pharmacy and patient convenience.
• May use with hydrophilic or lipophilic drugs.
• Naturally sweetened with monk fruit for a more palpable taste.
• Preservative free.
• Offers improved palatability from traditional oil vehicles.
• Mixes easily with water or juice.
• Ideal for use in pediatrics, including neonates.
• Appropriate for vet use (assess to ensure appropriate for the animal’s species).
• Can be used in polyurethane nasogastric (feeding) tubes.

PCCA Chief Scientific Officer Gus Bassani, PharmD, took center stage to announce the launch of our innovative SuspendIt Anhydrous at International Seminar 2022 (ISTX22). “Our research and development Team had to really innovate to get the delivery, the feel and other physical attributes just right. I tell you, you haven’t seen one like this before.”

Access more information here.